Biocentis, which controls insect populations with genetics, has raised $19 million to turn R&D into real-world deployments, CEO Giorgio Rocca tells Axios Pro.
Why it matters: Programmable biology that can control damaging insect groups could slash costs and reduce pesticide use.
